Plenary

Fostering Medical Device Improvement: FDA’s Voluntary Improvement Program

Wednesday, April 23, 2025

11:45 AM – 12:15 PM East Coast USA Time

Discover how the FDA’s Voluntary Improvement Program (VIP) is elevating manufacturing practices and behaviors through which quality and safety of medical devices can be improved. This session will introduce participants to the program's benefits and objectives, followed by an overview of the appraisal process that drives measurable improvements. Hear directly from program participants as they share their experiences and outcomes. Join us to learn how VIP can support your commitment to quality and continuous improvement.

Moderator(s)

Aaron Dunbar

Vice President of Quality Systems & Post Market
Boston Scientific

Speaker(s)

Kim Kaplan
EK

Erin Keith

Senior Advisor, Compliance and Quality Program, Office of Product Evaluation and Quality (OPEQ), Center for Devices and Radiological Health (CDRH)
FDA (Invited)
Brian Schultz

Vice President of Quality, Safety & Regulatory Affairs
Fisher & Paykel Healthcare
Keisha Thomas

Director of Compliance and Quality, Office of Product Evaluation and Quality (OPEQ), Center for Devices and Radiological Health (CDRH)
FDA (Invited)